Yiping Zhang

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

Junko Murai, Shar-yin N. Huang, Amèlie Renaud et al. · Molecular Cancer Therapeutics · 2013 · 758 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition

Junko Murai, Yiping Zhang, Joel Morris et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 286 citations · Full text

Medicine, Oncology, Pharmacology +17

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system

Christopher Linington, Thomas M. Berger, L Perry et al. · European Journal of Immunology · 1993 · 268 citations

Life Sciences, Immunology, Neuroscience +17

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

Baohui Han, Kai Li, Yizhuo Zhao et al. · British Journal of Cancer · 2018 · 263 citations · Full text

Medicine, Oncology, Pharmacology +16